Synthetic cannabinoids have become a new type of therapeutic drug for the treatment of epilepsy, spasticity, inflammation and so on.
This report contains market size and forecasts of Synthetic Cannabinoid in global, including the following market information:
Global Synthetic Cannabinoid Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Synthetic Cannabinoid Market Sales, 2017-2022, 2023-2028, (Ton)
Global top five Synthetic Cannabinoid companies in 2021 (%)
The global Synthetic Cannabinoid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
High-Pure Synthetic Cannabinoid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Synthetic Cannabinoid include Noramco, Hyasynth Biologicals, Insys Therapeutics, CV Sciences, Ginkgo Bioworks, CannBioRx Life Sciences, Renew Biopharma and Lygos (Librede), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Synthetic Cannabinoid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Synthetic Cannabinoid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Synthetic Cannabinoid Market Segment Percentages, by Type, 2021 (%)
High-Pure Synthetic Cannabinoid
Ultra-Pure Synthetic Cannabinoid
Global Synthetic Cannabinoid Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Synthetic Cannabinoid Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Consumer Good
Others
Global Synthetic Cannabinoid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Synthetic Cannabinoid Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Cannabinoid revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Synthetic Cannabinoid revenues share in global market, 2021 (%)
Key companies Synthetic Cannabinoid sales in global market, 2017-2022 (Estimated), (Ton)
Key companies Synthetic Cannabinoid sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Noramco
Hyasynth Biologicals
Insys Therapeutics
CV Sciences
Ginkgo Bioworks
CannBioRx Life Sciences
Renew Biopharma
Lygos (Librede)